{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-nausea-vomiting/management/end-of-life/","result":{"pageContext":{"chapter":{"id":"145fe4aa-682c-5299-9906-a7bca2e98a9b","slug":"end-of-life","fullItemName":"Scenario: End of life","depth":2,"htmlHeader":"<!-- begin field 6630ee73-bb73-466a-8286-bb417aad32dc --><h2>Scenario: End of life</h2><!-- end field 6630ee73-bb73-466a-8286-bb417aad32dc -->","summary":"Covers the identification of people at the end of life and the management of nausea and vomiting in this group.","htmlStringContent":"<!-- begin item 84a1ca35-1424-48a1-ba43-c27ee3d87c87 --><!-- begin field b252af9a-ad5b-4e40-b40e-acbc015bbb3c --><p>From age 16 years onwards.</p><!-- end field b252af9a-ad5b-4e40-b40e-acbc015bbb3c --><!-- end item 84a1ca35-1424-48a1-ba43-c27ee3d87c87 -->","topic":{"id":"8a2e6dd8-7d6f-5fcf-a744-1b12e2a14232","topicId":"329a162f-132a-4d7e-afd5-7ff2f86369d2","topicName":"Palliative care - nausea and vomiting","slug":"palliative-care-nausea-vomiting","lastRevised":"Last revised in October 2020","chapters":[{"id":"4cf6ed2e-fa29-54e9-8d93-4bd52407c5c4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2e3a3e75-af78-5547-a042-7aa68a341672","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"27d24f4a-dbc8-560f-b100-ca5287022d66","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b433057a-92f0-5457-837c-f3f7235e44e6","slug":"changes","fullItemName":"Changes"},{"id":"540b41fe-3e71-5c29-9379-7493711a8a59","slug":"update","fullItemName":"Update"}]},{"id":"ed201382-7c29-58e9-ba5d-f5c415eb3bf3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7043600f-13dd-5980-b06d-73dab2266896","slug":"goals","fullItemName":"Goals"},{"id":"63b87fa3-3c3d-527b-9ac2-e856dd0c559e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6e3ee330-3c0d-5735-b8d5-76b606865d07","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d1227949-2a90-5b29-abef-3895e05333c3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e2e036e5-217a-593d-947f-a8376f0f5e98","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3885ba7b-9d6f-5262-a541-463284363660","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b65bec71-2fa0-54e0-be57-13a917c2a697","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a9561403-d5a9-5c9c-b6e6-c24410e9d9d3","slug":"definition","fullItemName":"Definition"},{"id":"d92b4aee-031c-58a4-b4b9-5d13767e0261","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b1327253-7b93-5a44-b2f7-5e002ae90e8f","slug":"causes","fullItemName":"Causes"},{"id":"e321f36e-5ec2-5074-b128-109efef69a65","slug":"complications","fullItemName":"Complications"}]},{"id":"a4a81f08-7894-5ba4-a4e5-c5505f3e5250","fullItemName":"Management","slug":"management","subChapters":[{"id":"8691c12d-3ed6-5e16-bef3-667d198f6707","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"e2566bf0-9d82-5bc7-9b5f-835384f56bc2","slug":"known-cause","fullItemName":"Scenario: Known cause"},{"id":"c8237819-4755-5cd8-ad7c-12735068c87a","slug":"unknown-cause","fullItemName":"Scenario: Unknown cause"},{"id":"145fe4aa-682c-5299-9906-a7bca2e98a9b","slug":"end-of-life","fullItemName":"Scenario: End of life"}]},{"id":"4d9745dc-8b36-500d-8e94-0e51611a4373","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f61e929d-def9-58db-877e-a030bc91d3de","slug":"prescribing-an-anti-emetic","fullItemName":"Prescribing an anti-emetic"},{"id":"d39c4487-f9dc-5d1d-be98-95561ca991bd","slug":"prescribing-a-prokinetic","fullItemName":"Prescribing a prokinetic"},{"id":"23e74db2-9671-539b-8bcf-b5c4bdff23f9","slug":"prescribing-haloperidol","fullItemName":"Prescribing haloperidol"},{"id":"00a2a0a3-8bc1-5d27-a03f-6cd4624d1c38","slug":"prescribing-levomepromazine","fullItemName":"Prescribing levomepromazine"},{"id":"d0437d3a-566f-5df2-9800-1961ed4664e8","slug":"prescribing-cyclizine","fullItemName":"Prescribing cyclizine"},{"id":"e6d5c2a8-e2b8-55c5-afd4-46f2edcd4a30","slug":"prescribing-dexamethasone","fullItemName":"Prescribing dexamethasone"},{"id":"3042d096-a74b-5c66-8d18-8c233091e783","slug":"prescribing-hyoscine-butylbromide","fullItemName":"Prescribing hyoscine butylbromide"}]},{"id":"ba414d8a-38a1-5962-84ab-6051ffe6dfe9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"26e42d0a-9ee9-50c5-9f2b-818da289f6e9","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c0795c41-1865-5ab1-b820-e41b8b5d9aab","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3076afc1-a703-524e-9ec9-995b34c4d386","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"08b8fc57-db22-518d-a528-777cb4e8d7dc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"81928ac1-4f26-5da9-b11f-85d1cee4fbdd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5aee10d5-2771-547a-a52a-1fb430319da3","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3cfa53b2-3d63-508d-80ea-c2a6293844fc","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a4a81f08-7894-5ba4-a4e5-c5505f3e5250","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"62a056db-82e9-56d4-a0d6-74e091ba6473","slug":"how-to-recognize-the-terminal-phase","fullItemName":"How to recognize the terminal phase","depth":3,"htmlHeader":"<!-- begin field d1f072a1-a4a8-4d1a-9d8c-abe0864573f6 --><h3>How do I recognize the terminal phase?</h3><!-- end field d1f072a1-a4a8-4d1a-9d8c-abe0864573f6 -->","summary":null,"htmlStringContent":"<!-- begin item 3774793b-6288-460e-af05-302010300d2f --><!-- begin field aa1ad4b9-44f2-4a85-98b0-298e24ffd668 --><ul><li>It can often be difficult to be certain that a person is dying, but it is essential to recognize the signs of dying in order to appropriately care for people at the end of life.</li><li>The terminal phase may last hours to several days.</li><li>People are likely to be in the terminal phase of their illness when they:<ul><li>Deteriorate day by day or more rapidly</li><li>Have a reduced mobility and become progressively weak and fatigued without an apparent cause (for example hypercalcaemia).</li><li>Express a realization that they are dying</li><li>Have reduced cognition, ability to communicate and social withdrawal</li><li>Have a deterioration in level of consciousness</li><li>Are delirious, characterized by increased restlessness, confusion, and agitation</li><li>Are bed-bound</li><li>Take little food or fluid, and have difficulty taking oral medication.</li><li>Are peripherally cyanosed, have mottled skin and are cold to the touch</li><li>Have apnoea (whether awake or asleep) or an altered breathing pattern, such as Cheyne-Stokes breathing. </li></ul></li></ul><ul><li>For further details, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative cancer care - general issues</a>.</li></ul><!-- end field aa1ad4b9-44f2-4a85-98b0-298e24ffd668 --><!-- end item 3774793b-6288-460e-af05-302010300d2f -->","subChapters":[{"id":"a7f3d2cf-be7f-50c1-9139-914fe5cdd908","slug":"basis-for-recommendation-ffc","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 5db295c9-b38f-4b31-a4ce-9fb7340be117 --><h4>Basis for recommendation</h4><!-- end field 5db295c9-b38f-4b31-a4ce-9fb7340be117 -->","summary":null,"htmlStringContent":"<!-- begin item ffc1a38a-936b-4523-ab8c-f38414976566 --><!-- begin field 93d16469-6e35-49dd-bae3-76d7d1961da6 --><ul><li>The definition of the terminal phase in terms of timescale is based on a prospective study of 100 terminally ill cancer patients [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Morita et al, 1998</a>].</li><li>These recommendations are largely based on the National Institute for Health and Care Excellence (NICE) guideline Care of dying adults in the last days of life [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">NICE, 2015</a>]. The basis for the NICE recommendations has been briefly summarized in this section. For detailed information on the evidence NICE used to make these recommendations, see the full <a href=\"https://www.nice.org.uk/guidance/ng31/chapter/Recommendations\" data-hyperlink-id=\"28057833-8097-4d5d-a5b5-a98e00952930\">NICE guideline.</a></li></ul><!-- end field 93d16469-6e35-49dd-bae3-76d7d1961da6 --><!-- end item ffc1a38a-936b-4523-ab8c-f38414976566 -->","subChapters":[]}]},{"id":"b041b70b-de89-5ed0-945f-42b6e592ced2","slug":"simple-measures","fullItemName":"Simple measures","depth":3,"htmlHeader":"<!-- begin field b58332e4-89b2-48cc-a206-3a60972fbddb --><h3>What simple measures may help nausea and vomiting in palliative care?</h3><!-- end field b58332e4-89b2-48cc-a206-3a60972fbddb -->","summary":null,"htmlStringContent":"<!-- begin item 829fbd3b-304d-4588-a1ab-a0a81dd1a813 --><!-- begin field 572448a2-2075-48a2-ade7-397a16c41059 --><ul><li>Make sure the person has access to a large bowl, tissues, and water.</li><li>The sight and smell of food or drink may provoke nausea:<ul><li>Provide a calm environment away from where food is usually prepared or consumed.</li><li>If the person is usually responsible for cooking, make alternative arrangements.</li><li>Make sure that meals are small and palatable — snacks consisting of a few mouthfuls are less challenging than big meals.</li><li>Carbohydrate meals are often better tolerated.</li><li>Offer cool, fizzy drinks (citrus flavours are often preferred) — these are more palatable than still or hot drinks.</li></ul></li><li>Consider the use of complementary therapies; relaxation and acupressure bands may be useful to relieve symptoms.</li><li>Consider cognitive behavioural therapy for anticipatory nausea or vomiting.</li><li>In general, avoid nasogastric suction. It has no role in the management of most causes of nausea and vomiting.</li></ul><!-- end field 572448a2-2075-48a2-ade7-397a16c41059 --><!-- end item 829fbd3b-304d-4588-a1ab-a0a81dd1a813 -->","subChapters":[{"id":"8c487b98-e4e4-584d-bcee-05f849b5d987","slug":"basis-for-recommendation-a17","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a3d8ded2-7ff9-4cb5-8eea-2eb71325df64 --><h4>Basis for recommendation</h4><!-- end field a3d8ded2-7ff9-4cb5-8eea-2eb71325df64 -->","summary":null,"htmlStringContent":"<!-- begin item a175e6d9-b2b6-47e6-8557-83ab396242ad --><!-- begin field 2d21d489-8778-4580-b85f-d96ac65a042c --><p>These recommendations are based on palliative care literature from textbooks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Hardy, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Regnard, 2010</a>] published journal articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Wright, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Mannix, 2006</a>] and on the National Institute for Health and Care Excellence (NICE) guideline <em>Care of dying adults in the last days of life</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">NICE, 2015</a>] The basis for the NICE recommendations has been briefly summarized in this section. For detailed information on the evidence NICE used to make these recommendations, see the full <a href=\"https://www.nice.org.uk/guidance/ng31/chapter/Recommendations#pharmacological-interventions\" data-hyperlink-id=\"b0025344-d307-4697-99d7-a993003e6a9c\">NICE guideline</a>.</p><!-- end field 2d21d489-8778-4580-b85f-d96ac65a042c --><!-- end item a175e6d9-b2b6-47e6-8557-83ab396242ad -->","subChapters":[]}]},{"id":"0f650990-87be-557f-a3a8-23bb49fb792a","slug":"management-at-end-of-life","fullItemName":"Management at end of life","depth":3,"htmlHeader":"<!-- begin field 8c42e06a-8b38-4998-b7fa-900fe03952fe --><h3>How should I manage nausea and vomiting at the end of life?</h3><!-- end field 8c42e06a-8b38-4998-b7fa-900fe03952fe -->","summary":null,"htmlStringContent":"<!-- begin item e1bd87bf-198b-424e-be90-643c4c0f35c5 --><!-- begin field da760321-8c6f-4b46-aa5f-30276d4d5607 --><ul><li>Assess for likely causes of nausea or vomiting in the dying person. See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/management/assessment/\">Scenario: Assessment</a><font color=\"#0782c1\">.</font></li><li>Discuss the options for treating nausea and vomiting with the dying person and those people important to them.</li><li>Consider non-pharmacological <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/management/known-cause/#simple-measures\">simple measures</a> for treating nausea and vomiting.</li><li>When choosing medicines to manage nausea or vomiting in a person in the last days of life, take into account:<ul><li>The likely cause and if it is reversible.</li><li>The side effects, including sedative effects, of the medicine.</li><li>Other symptoms the person has.</li><li>The desired balancing of effects when managing other symptoms.</li><li>Compatibility and drug interactions with other medicines the person is taking.</li></ul></li><li><strong>If an anti-emetic already controls symptoms well:</strong><ul><li>Continue with the same drug.</li><li>Give the same drug by syringe driver if the person becomes unable to take oral medication. If an injectable form is not available, use a drug with a similar mode of action.</li></ul></li><li><strong>For new or uncontrolled nausea and vomiting:</strong><ul><li>If appropriate, try to determine the underlying cause of nausea and vomiting and manage accordingly. See <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/management/known-cause/\">Scenario: Known cause </a>.</li><li>Otherwise give levomepromazine 6.25 mg once daily by subcutaneous injection. Repeat the dose after 1 hour if needed.</li><li>If a repeat dose is needed, start levomepromazine by continuous subcutaneous injection:<ul><li>Start at a dose of 12.5 mg in 24 hours, plus a 6.25 mg subcutaneous injection as needed.</li><li>If one or more extra doses are needed, increase the dose to 25 mg in 24 hours.</li></ul></li></ul></li><li><strong>For people in the last days of life with obstructive bowel disorders who have nausea or vomiting, consider:</strong><ul><li>Hyoscine butylbromide (off-label indication) as the first-line pharmacological treatment.</li><li>If the symptoms do not improve within 24 hours of starting hyoscine the recommended second line treatment is octreotide (off-label indication).</li><li>If symptoms remain uncontrolled, contact the local palliative care team for advice.</li><li>Review the effectiveness of anti-emetic treatment every 24 hours.</li><li>For more information on recognizing the terminal phase and issues relating to caring for a person and their family at this time, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>.</li></ul></li></ul><!-- end field da760321-8c6f-4b46-aa5f-30276d4d5607 --><!-- end item e1bd87bf-198b-424e-be90-643c4c0f35c5 -->","subChapters":[{"id":"c2f9f45d-c1ee-572c-89cb-131aa0a3767d","slug":"basis-for-recommendation-257","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 5b215c2f-407d-4fb1-a893-52a665842001 --><h4>Basis for recommendation</h4><!-- end field 5b215c2f-407d-4fb1-a893-52a665842001 -->","summary":null,"htmlStringContent":"<!-- begin item 257de9ab-de5a-4cbc-8525-bab8a959444e --><!-- begin field 5befebe7-ad11-4cf1-acae-0db8e2db0cf4 --><p>These recommendations are largely based on the UK specialist palliative care guidelines on nausea and vomiting at the end of life [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Northern England Clinical Networks, 2016</a>] and the National Institute for Health and Care Excellence (NICE) guideline <em>Care of dying adults in the last days of life </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">NICE, 2015</a>].The basis for the NICE recommendations has been briefly summarized in this section. For detailed information on the evidence NICE used to make these recommendations, see the full <a href=\"https://www.nice.org.uk/guidance/ng31/chapter/Recommendations\" data-hyperlink-id=\"7109beac-9f2e-49b5-887c-a98c00f9802b\">NICE guideline</a>.</p><!-- end field 5befebe7-ad11-4cf1-acae-0db8e2db0cf4 --><!-- end item 257de9ab-de5a-4cbc-8525-bab8a959444e -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}